Ü. Y. Malkan And I. C. Haznedaroglu, "Chronic myeloid leukemia, tyrosine kinase inhibitors and cardiovascular system.," European review for medical and pharmacological sciences , vol.27, no.12, pp.5493-5506, 2023
Malkan, Ü. Y. And Haznedaroglu, I. C. 2023. Chronic myeloid leukemia, tyrosine kinase inhibitors and cardiovascular system.. European review for medical and pharmacological sciences , vol.27, no.12 , 5493-5506.
Malkan, Ü. Y., & Haznedaroglu, I. C., (2023). Chronic myeloid leukemia, tyrosine kinase inhibitors and cardiovascular system.. European review for medical and pharmacological sciences , vol.27, no.12, 5493-5506.
Malkan, ÜMİT, And I C Haznedaroglu. "Chronic myeloid leukemia, tyrosine kinase inhibitors and cardiovascular system.," European review for medical and pharmacological sciences , vol.27, no.12, 5493-5506, 2023
Malkan, ÜMİT Y. And Haznedaroglu, I C. . "Chronic myeloid leukemia, tyrosine kinase inhibitors and cardiovascular system.." European review for medical and pharmacological sciences , vol.27, no.12, pp.5493-5506, 2023
Malkan, Ü. Y. And Haznedaroglu, I. C. (2023) . "Chronic myeloid leukemia, tyrosine kinase inhibitors and cardiovascular system.." European review for medical and pharmacological sciences , vol.27, no.12, pp.5493-5506.
@article{article, author={ÜMİT YAVUZ MALKAN And author={I C Haznedaroglu}, title={Chronic myeloid leukemia, tyrosine kinase inhibitors and cardiovascular system.}, journal={European review for medical and pharmacological sciences}, year=2023, pages={5493-5506} }